US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6544771B1
(en)
|
1987-12-11 |
2003-04-08 |
Cell Genesys, Inc. |
Retroviral gene therapy vectors and therapeutic methods based thereon
|
US5580776A
(en)
*
|
1988-02-05 |
1996-12-03 |
Howard Hughes Medical Institute |
Modified hepatocytes and uses therefor
|
WO1989007136A2
(en)
|
1988-02-05 |
1989-08-10 |
Whitehead Institute For Biomedical Research |
Modified hepatocytes and uses therefor
|
US5650148A
(en)
*
|
1988-12-15 |
1997-07-22 |
The Regents Of The University Of California |
Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
|
US7238673B2
(en)
*
|
1989-03-31 |
2007-07-03 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
AU7312891A
(en)
*
|
1990-02-12 |
1991-09-03 |
Board Of Regents, The University Of Texas System |
Satellite cell proliferation in adult skeletal muscle
|
FR2662698A1
(fr)
*
|
1990-06-05 |
1991-12-06 |
Centre Nat Rech Scient |
Nouveaux facteurs de croissance neurotropes comprenant un peptide homeoboite.
|
US5269785A
(en)
*
|
1990-06-28 |
1993-12-14 |
Bonutti Peter M |
Apparatus and method for tissue removal
|
US5849572A
(en)
*
|
1990-10-10 |
1998-12-15 |
Regents Of The University Of Michigan |
HSV-1 vector containing a lat promoter
|
US5849571A
(en)
*
|
1990-10-10 |
1998-12-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Latency active herpes virus promoters and their use
|
US5618531A
(en)
*
|
1990-10-19 |
1997-04-08 |
New York University |
Method for increasing the viability of cells which are administered to the brain or spinal cord
|
WO1992007945A1
(en)
*
|
1990-10-30 |
1992-05-14 |
Dana Farber Cancer Institute |
Cell type specific alteration of levels of gene products in neural cells
|
CA2076848A1
(en)
*
|
1990-12-26 |
1992-06-27 |
Richard C. Mulligan |
Modified hepatocytes and uses therefor
|
EP0585368B1
(de)
*
|
1991-04-25 |
1997-08-06 |
Brown University Research Foundation |
Implantierbare, biokompatible immunisolator-trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
|
US5800829A
(en)
*
|
1991-04-25 |
1998-09-01 |
Brown University Research Foundation |
Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
|
US6294346B1
(en)
|
1991-07-08 |
2001-09-25 |
Neurospheres Holdings, Ltd. |
Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
|
US7361505B1
(en)
|
1991-07-08 |
2008-04-22 |
Neurospheres Holdings Ltd. |
Multipotent neural stem cell compositions
|
US6497872B1
(en)
*
|
1991-07-08 |
2002-12-24 |
Neurospheres Holdings Ltd. |
Neural transplantation using proliferated multipotent neural stem cells and their progeny
|
US6071889A
(en)
*
|
1991-07-08 |
2000-06-06 |
Neurospheres Holdings Ltd. |
In vivo genetic modification of growth factor-responsive neural precursor cells
|
US6399369B1
(en)
*
|
1991-07-08 |
2002-06-04 |
Neurospheres Holdings Ltd. |
Multipotent neural stem cell cDNA libraries
|
US5851832A
(en)
*
|
1991-07-08 |
1998-12-22 |
Neurospheres, Ltd. |
In vitro growth and proliferation of multipotent neural stem cells and their progeny
|
US5980885A
(en)
*
|
1991-07-08 |
1999-11-09 |
Neurospheres Holdings Ltd. |
Growth factor-induced proliferation of neural precursor cells in vivo
|
US5981165A
(en)
*
|
1991-07-08 |
1999-11-09 |
Neurospheres Holdings Ltd. |
In vitro induction of dopaminergic cells
|
US5750376A
(en)
*
|
1991-07-08 |
1998-05-12 |
Neurospheres Holdings Ltd. |
In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
|
US7166277B1
(en)
*
|
1991-07-08 |
2007-01-23 |
Neurospheres Holdings Ltd. |
Remyelination of neurons using multipotent neural stem cell progeny
|
US6503277B2
(en)
*
|
1991-08-12 |
2003-01-07 |
Peter M. Bonutti |
Method of transplanting human body tissue
|
US5329846A
(en)
|
1991-08-12 |
1994-07-19 |
Bonutti Peter M |
Tissue press and system
|
US5529774A
(en)
*
|
1991-08-13 |
1996-06-25 |
The Regents Of The University Of California |
In vivo transfer of the HSV-TK gene implanted retroviral producer cells
|
US6214334B1
(en)
*
|
1991-10-21 |
2001-04-10 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for producing and using homogenous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuries
|
US5968502A
(en)
|
1991-11-05 |
1999-10-19 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
NZ245015A
(en)
*
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US6270989B1
(en)
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
DK0625195T3
(da)
*
|
1991-11-15 |
1999-08-30 |
Univ California |
Behandling af centralnervesystemet med genetisk modificerede celler
|
EP0673259A4
(de)
*
|
1992-01-23 |
1995-12-06 |
Univ New York |
Methode zur transplantation von zellen ins gehirn und therapeutische verwendungen davon.
|
EP0584339A4
(en)
*
|
1992-03-04 |
1996-02-28 |
Jon A Wolff |
Method of delivering therapeutic substances to the brain
|
US6087323A
(en)
*
|
1992-04-03 |
2000-07-11 |
Cambridge Neuroscience, Inc. |
Use of neuregulins as modulators of cellular communication
|
US5688936A
(en)
*
|
1992-06-11 |
1997-11-18 |
The Regents Of The University Of California |
Vesicle membrane transport proteins
|
WO1994001135A1
(en)
*
|
1992-07-06 |
1994-01-20 |
The Research Foundation Of State University Of New York |
Method of producing genetically modified astrocytes and uses thereof
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
JPH08501686A
(ja)
*
|
1992-09-25 |
1996-02-27 |
ローン−プーラン・ロレ・ソシエテ・アノニム |
中枢神経系、特に脳における細胞への外来遺伝子の転移のためのアデノウィルスベクター
|
US5266588A
(en)
*
|
1992-09-25 |
1993-11-30 |
Bristol-Myers Squibb Company |
Compound produced by a strain of microtetraspora having antibacterial and neuritogenic activity
|
US5766948A
(en)
|
1993-01-06 |
1998-06-16 |
The Regents Of The University Of California |
Method for production of neuroblasts
|
DE69433661T2
(de)
*
|
1993-01-29 |
2005-02-10 |
Neurospheres Holding Ltd., Calgary |
Genetische modifikation von neuralen stammzellen
|
US5753491A
(en)
*
|
1993-04-13 |
1998-05-19 |
Us Health |
Use of neuro-derived fetal cell lines for transplantation therapy
|
JPH08509215A
(ja)
*
|
1993-04-13 |
1996-10-01 |
アメリカ合衆国 |
移植治療のための神経由来胎児セルラインの使用
|
FR2704556B1
(fr)
*
|
1993-04-30 |
1995-07-13 |
Rhone Poulenc Rorer Sa |
Virus recombinants et leur utilisation en thérapie génique.
|
FR2707091B1
(fr)
*
|
1993-06-30 |
1997-04-04 |
Cohen Haguenauer Odile |
Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
|
CA2169292C
(en)
*
|
1993-08-12 |
2010-11-23 |
E. Edward Baetge |
Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5908623A
(en)
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
CN1141058A
(zh)
*
|
1993-11-09 |
1997-01-22 |
纽罗斯菲里斯控股有限公司 |
中枢神经系统干细胞的原位修饰和处理
|
CA2146735C
(en)
*
|
1994-04-11 |
2007-02-20 |
Chise Tateno |
Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes
|
US5714353A
(en)
*
|
1994-05-24 |
1998-02-03 |
Research Corporation Technologies, Inc. |
Safe vectors for gene therapy
|
FR2721943B1
(fr)
*
|
1994-06-29 |
1996-08-02 |
Rhone Poulenc Rorer Sa |
Adenovirus comprenant un gene codant pour une superoxyde dismutase
|
US5834029A
(en)
*
|
1994-07-20 |
1998-11-10 |
Cytotherapeutics, Inc. |
Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
|
US5776747A
(en)
*
|
1994-07-20 |
1998-07-07 |
Cytotherapeutics, Inc. |
Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
|
US5935849A
(en)
|
1994-07-20 |
1999-08-10 |
Cytotherapeutics, Inc. |
Methods and compositions of growth control for cells encapsulated within bioartificial organs
|
FR2723588B1
(fr)
|
1994-08-12 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Adenovirus comprenant un gene codant pour la glutathion peroxydase
|
US6103226A
(en)
*
|
1994-08-12 |
2000-08-15 |
Arch Development Corporation |
Genetically engineered cells that produce produce L. Dopa
|
WO1996012501A1
(en)
|
1994-10-19 |
1996-05-02 |
Human Genome Sciences, Inc. |
Human hypoxanthine-(guanine) phosphoribosyl transferase-2
|
CA2204355C
(en)
|
1994-11-02 |
2001-01-16 |
Gail Mandel |
Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
|
US6204053B1
(en)
|
1994-11-08 |
2001-03-20 |
Diacrin, Inc. |
Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
|
US6277372B1
(en)
*
|
1994-11-08 |
2001-08-21 |
Diacrin, Inc. |
Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
|
US6294383B1
(en)
|
1994-11-08 |
2001-09-25 |
The Mclean Hospital Corporation |
Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
|
FR2727429B1
(fr)
|
1994-11-30 |
1997-11-28 |
Haguenauer Odile Cohen |
Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs
|
EP1006801A4
(de)
*
|
1995-03-13 |
2001-05-02 |
Univ South Florida |
Sertoli-zellen als indikatoren der neuroregeneration in neurodegenerativen erkrankungen
|
US5702700A
(en)
*
|
1995-03-13 |
1997-12-30 |
University Of South Florida |
Sertoli cells as neurorecovery inducing cells for Parkinson's disease
|
US5681744A
(en)
*
|
1995-03-17 |
1997-10-28 |
Greenstein; Robert J. |
Delivery and expression of heterologus genes using upstream enhancer regions of mammalian gene promoters
|
US6653134B2
(en)
*
|
1995-03-28 |
2003-11-25 |
Cp Hahnemann University |
Isolated stromal cells for use in the treatment of diseases of the central nervous system
|
US6974571B2
(en)
*
|
1995-03-28 |
2005-12-13 |
Thomas Jefferson University |
Isolated stromal cells and methods of using the same
|
US6576607B1
(en)
*
|
1995-04-19 |
2003-06-10 |
Acorda Therapeutics |
Methods using CNS neurite outgrowth modulators
|
AU5390696A
(en)
*
|
1995-04-20 |
1996-11-07 |
University Of South Florida |
Purified and isolated sertoli cell aggregate
|
US6033660A
(en)
*
|
1995-05-10 |
2000-03-07 |
Genentech, Inc. |
Method of treating a nervous system injury with cultured schwann cells
|
US5721139A
(en)
*
|
1995-05-10 |
1998-02-24 |
Genentech, Inc. |
Isolating and culturing schwann cells
|
US5849585A
(en)
*
|
1995-05-10 |
1998-12-15 |
Genetech, Inc. |
Isolating and culturing Schwann cells
|
US5714385A
(en)
*
|
1995-05-10 |
1998-02-03 |
Genentech, Inc. |
Media for culturing schwann cells
|
US6495364B2
(en)
*
|
1995-05-23 |
2002-12-17 |
Neurotech, S.A. |
Mx-1 conditionally immortalized cells
|
WO1996039416A1
(en)
*
|
1995-06-06 |
1996-12-12 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for pituitary adenoma and other endocrine disorders
|
AU742824C
(en)
*
|
1995-06-06 |
2003-03-20 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Use of neuro-derived fetal cell lines for transplantation therapy
|
US6306649B1
(en)
*
|
1995-06-27 |
2001-10-23 |
Ariad Gene Therapeutics, Inc. |
Heterologous transcription factors
|
US5753505A
(en)
*
|
1995-07-06 |
1998-05-19 |
Emory University |
Neuronal progenitor cells and uses thereof
|
US5800812A
(en)
*
|
1995-09-15 |
1998-09-01 |
Yeda Research And Development Co. Ltd. |
Methods of use of mononuclear phagocytes to promote axonal regeneration
|
US6267955B1
(en)
|
1995-09-15 |
2001-07-31 |
Yeda Research And Development Co. Ltd. |
Mononuclear phagocytes and their use to promote axonal regeneration
|
US20020006660A1
(en)
*
|
1996-03-01 |
2002-01-17 |
Rhone-Poulenc Rorer, S.A. |
Genetically-modified neural progenitors and uses thereof
|
CA2247912A1
(en)
*
|
1996-03-04 |
1997-09-12 |
University Of Medicine & Dentistry Of New Jersey |
Genetically engineered primary oligodendrocytes for transplantation-mediated gene delivery in the central nervous system
|
US6037175A
(en)
*
|
1996-03-12 |
2000-03-14 |
The University Of South Florida |
Method and media for enhancing cryopreservation of cells
|
FR2746109B1
(fr)
|
1996-03-12 |
1998-04-17 |
Rhone Poulenc Rorer Sa |
Milieu pour la conservation de materiel biologique
|
US7544511B2
(en)
*
|
1996-09-25 |
2009-06-09 |
Neuralstem Biopharmaceuticals Ltd. |
Stable neural stem cell line methods
|
US6759499B1
(en)
*
|
1996-07-16 |
2004-07-06 |
Exxonmobil Chemical Patents Inc. |
Olefin polymerization process with alkyl-substituted metallocenes
|
US5718717A
(en)
|
1996-08-19 |
1998-02-17 |
Bonutti; Peter M. |
Suture anchor
|
US6713247B1
(en)
|
1996-09-03 |
2004-03-30 |
Signal Pharmaceuticials, Inc. |
Human CNS cell lines and methods of use therefor
|
US20040086494A1
(en)
*
|
1996-10-07 |
2004-05-06 |
John Constance Mary |
Immune privileged cells for delivery of proteins and peptides
|
JP2001513643A
(ja)
*
|
1997-03-06 |
2001-09-04 |
ウーベルラ、クラウス |
レンチウイルスをベースとするベクター及びベクター系
|
WO1998045420A1
(en)
*
|
1997-04-10 |
1998-10-15 |
Diagnocure Inc. |
Pca3, pca3 genes, and methods of use
|
IT1292017B1
(it)
*
|
1997-05-28 |
1999-01-25 |
Dompe Spa |
Composizioni farmaceutiche contenenti la proteina stimolante i macrofagi per il trattamento di patologie del sistema nervoso
|
AU749530B2
(en)
*
|
1997-06-11 |
2002-06-27 |
Acorda Therapeutics, Inc. |
CNS neuroregenerative compositions and methods of use
|
US20030121064A1
(en)
*
|
1997-06-11 |
2003-06-26 |
Ann Logan |
CNS neuroregenerative compositions and methods of use
|
WO1998056393A1
(en)
*
|
1997-06-13 |
1998-12-17 |
University Technology Corporation |
Transplantation of immortalized dopamine cells to improve neurological deficits
|
US6167888B1
(en)
*
|
1997-06-30 |
2001-01-02 |
The Regents Of The University Of California |
Method for inducing partial recovery of lost voluntary motor function after spinal cord injury in a mammal
|
US6475230B1
(en)
*
|
1997-08-01 |
2002-11-05 |
Peter M. Bonutti |
Method and apparatus for securing a suture
|
US7923216B2
(en)
*
|
1997-08-14 |
2011-04-12 |
Institut Pasteur |
In vivo modulation of neuronal transport
|
PT1049712E
(pt)
*
|
1997-08-14 |
2007-04-30 |
Pasteur Institut |
Proteínas híbridas da toxina do tétano que migram retrogradamente e trans - sinapticamente para o snc
|
US20100081197A1
(en)
*
|
1997-08-14 |
2010-04-01 |
Sylvie Roux |
In vivo modulation of neuronal transport
|
US7923015B2
(en)
*
|
1997-08-14 |
2011-04-12 |
Institut Pasteur |
Methods for direct visualization of active synapses
|
US5968829A
(en)
*
|
1997-09-05 |
1999-10-19 |
Cytotherapeutics, Inc. |
Human CNS neural stem cells
|
US6093531A
(en)
*
|
1997-09-29 |
2000-07-25 |
Neurospheres Holdings Ltd. |
Generation of hematopoietic cells from multipotent neural stem cells
|
US6045551A
(en)
|
1998-02-06 |
2000-04-04 |
Bonutti; Peter M. |
Bone suture
|
WO1999047158A2
(en)
*
|
1998-03-13 |
1999-09-23 |
The University Of British Columbia |
Therapeutic chemokine receptor antagonists
|
CA2305787A1
(en)
*
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
CA2245224A1
(en)
*
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
US6451306B1
(en)
*
|
1998-04-15 |
2002-09-17 |
The Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
US7157435B2
(en)
|
1998-04-15 |
2007-01-02 |
The Regents Of The University Of California |
Methods for modulation of the effects of aging on the primate brain
|
US6815431B2
(en)
|
1998-04-15 |
2004-11-09 |
Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
US6683058B1
(en)
|
1998-04-15 |
2004-01-27 |
Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
US6027744A
(en)
*
|
1998-04-24 |
2000-02-22 |
University Of Massachusetts Medical Center |
Guided development and support of hydrogel-cell compositions
|
US6171610B1
(en)
|
1998-04-24 |
2001-01-09 |
University Of Massachusetts |
Guided development and support of hydrogel-cell compositions
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
WO2000006700A1
(en)
*
|
1998-07-29 |
2000-02-10 |
Layton Bioscience, Inc. |
Production and use of dopaminergic cells to treat dopaminergic deficiencies
|
US6444205B2
(en)
|
1998-09-30 |
2002-09-03 |
Diacrin, Inc. |
Transplantation of neural cells for the treatment of chronic pain or spasticity
|
US7399751B2
(en)
*
|
1999-11-04 |
2008-07-15 |
Sertoli Technologies, Inc. |
Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
|
US8778899B2
(en)
*
|
1999-06-01 |
2014-07-15 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
DE19928210B4
(de)
*
|
1999-06-19 |
2005-08-18 |
Neuroprogen Gmbh Leipzig |
Neuronales Zellmaterial und Verfahren zu dessen Herstellung
|
US6447516B1
(en)
|
1999-08-09 |
2002-09-10 |
Peter M. Bonutti |
Method of securing tissue
|
US6368343B1
(en)
|
2000-03-13 |
2002-04-09 |
Peter M. Bonutti |
Method of using ultrasonic vibration to secure body tissue
|
PT1222266E
(pt)
*
|
1999-09-29 |
2006-07-31 |
Diagnocure Inc |
Arn mensageiro de pca3 em tecidos benignos e malignos da prostata
|
US7560275B2
(en)
*
|
1999-12-30 |
2009-07-14 |
Vbi Technologies, L.L.C. |
Compositions and methods for generating skin
|
US7575921B2
(en)
*
|
1999-12-30 |
2009-08-18 |
Vbi Technologies, L.L.C. |
Spore-like cells and uses thereof
|
US6635073B2
(en)
|
2000-05-03 |
2003-10-21 |
Peter M. Bonutti |
Method of securing body tissue
|
US7368425B2
(en)
*
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
CA2335109A1
(en)
*
|
2000-04-12 |
2001-10-12 |
Chemokine Therapeutics Corporation |
Cxcr4 agonist treatment of hematopoietic cells
|
US7378098B2
(en)
*
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
US20050059584A1
(en)
*
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
AU2001251599B2
(en)
*
|
2000-04-14 |
2006-03-02 |
University Of Pittsburgh |
Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
|
US7037493B2
(en)
|
2000-05-01 |
2006-05-02 |
Cornell Research Foundation, Inc. |
Method of inducing neuronal production in the brain and spinal cord
|
US6897061B1
(en)
|
2000-06-16 |
2005-05-24 |
Spinal Cord Society |
Transdifferentiation of glial cells
|
JP4031901B2
(ja)
*
|
2000-07-19 |
2008-01-09 |
株式会社東芝 |
固体撮像装置
|
NZ524070A
(en)
*
|
2000-07-19 |
2008-05-30 |
Univ California |
Methods for therapy of neurodegenerative disease of the non-human brain
|
US20020151050A1
(en)
*
|
2000-10-30 |
2002-10-17 |
Vacanti Charles A. |
Isolation of spore-like cells from tissues exposed to extreme conditions
|
US20060280724A1
(en)
*
|
2000-11-04 |
2006-12-14 |
Ferguson Ian A |
Identification of ligands that enable endocytosis, using in vivo manipulation of neuronal fibers
|
EP1335972A2
(de)
*
|
2000-11-22 |
2003-08-20 |
Geron Corporation |
Toleranz-induzierende allotransplantate aus pluripotenten stammzellen
|
US6576464B2
(en)
|
2000-11-27 |
2003-06-10 |
Geron Corporation |
Methods for providing differentiated stem cells
|
US6921665B2
(en)
|
2000-11-27 |
2005-07-26 |
Roslin Institute (Edinburgh) |
Selective antibody targeting of undifferentiated stem cells
|
EP1385938A1
(de)
*
|
2001-04-23 |
2004-02-04 |
Nsgene A/S |
Methode und kulturmedium zur herstellung von neuronalenzellen ausdrücken tyrosin hydroxylase
|
US6719765B2
(en)
|
2001-12-03 |
2004-04-13 |
Bonutti 2003 Trust-A |
Magnetic suturing system and method
|
US7576065B2
(en)
*
|
2002-02-15 |
2009-08-18 |
Cornell Research Foundation, Inc. |
Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
|
US8293488B2
(en)
|
2002-12-09 |
2012-10-23 |
Neuralstem, Inc. |
Method for screening neurogenic agents
|
WO2004053071A2
(en)
*
|
2002-12-09 |
2004-06-24 |
Judith Kelleher-Andersson |
Method for discovering neurogenic agents
|
US8551100B2
(en)
|
2003-01-15 |
2013-10-08 |
Biomet Manufacturing, Llc |
Instrumentation for knee resection
|
US7837690B2
(en)
*
|
2003-01-15 |
2010-11-23 |
Biomet Manufacturing Corp. |
Method and apparatus for less invasive knee resection
|
US7789885B2
(en)
*
|
2003-01-15 |
2010-09-07 |
Biomet Manufacturing Corp. |
Instrumentation for knee resection
|
US7887542B2
(en)
*
|
2003-01-15 |
2011-02-15 |
Biomet Manufacturing Corp. |
Method and apparatus for less invasive knee resection
|
US20050282170A1
(en)
|
2003-02-07 |
2005-12-22 |
Diagnocure Inc. |
Method to detect prostate cancer in a sample
|
AU2003267969A1
(en)
*
|
2003-04-17 |
2004-11-26 |
U.S. Department Of Veterans Affairs |
Isolated/cloned human nt2 cell lines expressing serotonin and gaba
|
US7459152B2
(en)
*
|
2003-04-23 |
2008-12-02 |
Rush University Medical Center |
Erythropoietin administration to improve graft survival
|
CN1812800B
(zh)
*
|
2003-04-25 |
2013-01-16 |
匹兹堡大学 |
用于促进和增强神经修复和再生的肌肉来源的细胞(mdc)
|
JP4926703B2
(ja)
*
|
2003-07-03 |
2012-05-09 |
セルトリ・テクノロジーズ・エルエルシー |
セルトリ細胞および筋様細胞を含有する組成物、並びに細胞性移植における該組成物の使用
|
US20050013870A1
(en)
*
|
2003-07-17 |
2005-01-20 |
Toby Freyman |
Decellularized extracellular matrix of conditioned body tissues and uses thereof
|
US7326571B2
(en)
*
|
2003-07-17 |
2008-02-05 |
Boston Scientific Scimed, Inc. |
Decellularized bone marrow extracellular matrix
|
WO2005033297A1
(en)
*
|
2003-09-19 |
2005-04-14 |
The Rockefeller University |
Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
|
US20050070379A1
(en)
*
|
2003-09-26 |
2005-03-31 |
Todd Gilmour |
Rite-Hite Golf Tee
|
US7488324B1
(en)
|
2003-12-08 |
2009-02-10 |
Biomet Manufacturing Corporation |
Femoral guide for implanting a femoral knee prosthesis
|
EP2289911A3
(de)
|
2004-03-30 |
2011-03-30 |
NsGene A/S |
Therapeutische Verwendung des Wachstumsfaktors nsg33
|
PL1758986T3
(pl)
|
2004-06-09 |
2016-03-31 |
Univ Court Univ Of Edinburgh |
Nerwowe komórki macierzyste
|
US20090136552A1
(en)
*
|
2004-07-30 |
2009-05-28 |
Mette Gronborg |
Growth factors nsg28, nsg30, and nsg32
|
KR101505347B1
(ko)
|
2004-11-17 |
2015-03-23 |
뉴럴스템, 인크. |
신경퇴행성 증상의 치료를 위한 인간 신경 세포의 이식
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
CA2491067A1
(en)
*
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
CN101155912A
(zh)
*
|
2005-01-31 |
2008-04-02 |
同源治疗公司 |
显示出内皮细胞特征的脂肪来源的成年基质细胞
|
US20070092449A1
(en)
*
|
2005-04-05 |
2007-04-26 |
Rafael Vazquez-Martinez |
Methods for direct visualization of active synapses
|
US7695479B1
(en)
|
2005-04-12 |
2010-04-13 |
Biomet Manufacturing Corp. |
Femoral sizer
|
TW200726474A
(en)
*
|
2005-07-15 |
2007-07-16 |
Cognate Therapeutics Inc |
The immunophenotype and immunogenicity of human adipose derived cells
|
WO2007024391A2
(en)
|
2005-07-22 |
2007-03-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Light-activated cation channel and uses thereof
|
US20090093403A1
(en)
|
2007-03-01 |
2009-04-09 |
Feng Zhang |
Systems, methods and compositions for optical stimulation of target cells
|
US10052497B2
(en)
*
|
2005-07-22 |
2018-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
US9238150B2
(en)
*
|
2005-07-22 |
2016-01-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optical tissue interface method and apparatus for stimulating cells
|
US9274099B2
(en)
|
2005-07-22 |
2016-03-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
|
US8926959B2
(en)
|
2005-07-22 |
2015-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
US8357666B2
(en)
*
|
2005-08-01 |
2013-01-22 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through RNA interference
|
US20070093439A1
(en)
*
|
2005-10-25 |
2007-04-26 |
Idera Pharmaceuticals, Inc. |
Short immunomodulatory oligonucleotides
|
JP5247468B2
(ja)
*
|
2005-12-30 |
2013-07-24 |
ニューロテック ユーエスエー, インコーポレイテッド |
生物活性分子の送達のための微粒子化デバイスおよびその使用方法
|
US20070178137A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Toby Freyman |
Local control of inflammation
|
US9113971B2
(en)
|
2006-02-27 |
2015-08-25 |
Biomet Manufacturing, Llc |
Femoral acetabular impingement guide
|
US8591516B2
(en)
|
2006-02-27 |
2013-11-26 |
Biomet Manufacturing, Llc |
Patient-specific orthopedic instruments
|
US9907659B2
(en)
|
2007-04-17 |
2018-03-06 |
Biomet Manufacturing, Llc |
Method and apparatus for manufacturing an implant
|
US9345548B2
(en)
|
2006-02-27 |
2016-05-24 |
Biomet Manufacturing, Llc |
Patient-specific pre-operative planning
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
US8407067B2
(en)
|
2007-04-17 |
2013-03-26 |
Biomet Manufacturing Corp. |
Method and apparatus for manufacturing an implant
|
US20150335438A1
(en)
|
2006-02-27 |
2015-11-26 |
Biomet Manufacturing, Llc. |
Patient-specific augments
|
US8070752B2
(en)
*
|
2006-02-27 |
2011-12-06 |
Biomet Manufacturing Corp. |
Patient specific alignment guide and inter-operative adjustment
|
US10278711B2
(en)
|
2006-02-27 |
2019-05-07 |
Biomet Manufacturing, Llc |
Patient-specific femoral guide
|
US9289253B2
(en)
|
2006-02-27 |
2016-03-22 |
Biomet Manufacturing, Llc |
Patient-specific shoulder guide
|
US9173661B2
(en)
|
2006-02-27 |
2015-11-03 |
Biomet Manufacturing, Llc |
Patient specific alignment guide with cutting surface and laser indicator
|
US9339278B2
(en)
|
2006-02-27 |
2016-05-17 |
Biomet Manufacturing, Llc |
Patient-specific acetabular guides and associated instruments
|
US9918740B2
(en)
|
2006-02-27 |
2018-03-20 |
Biomet Manufacturing, Llc |
Backup surgical instrument system and method
|
US8603180B2
(en)
|
2006-02-27 |
2013-12-10 |
Biomet Manufacturing, Llc |
Patient-specific acetabular alignment guides
|
US7780672B2
(en)
*
|
2006-02-27 |
2010-08-24 |
Biomet Manufacturing Corp. |
Femoral adjustment device and associated method
|
US20100030102A1
(en)
*
|
2006-05-15 |
2010-02-04 |
David Poston |
Active Delivery and Flow Redirections: Novel Devices and Method of Delivery of Materials to Patients
|
US7998128B2
(en)
|
2006-05-15 |
2011-08-16 |
Therataxis, LLC. |
Active delivery and flow redirection: novel devices and method of delivery of materials to patients
|
US7695520B2
(en)
*
|
2006-05-31 |
2010-04-13 |
Biomet Manufacturing Corp. |
Prosthesis and implementation system
|
WO2007142540A1
(en)
|
2006-06-07 |
2007-12-13 |
Otago Innovation Limited |
Diagnostic methods and markers
|
US9795399B2
(en)
|
2006-06-09 |
2017-10-24 |
Biomet Manufacturing, Llc |
Patient-specific knee alignment guide and associated method
|
EP2051726B1
(de)
|
2006-07-18 |
2018-04-18 |
University of Utah Research Foundation |
Verfahren zur behandlung von schmerzen und screening von analgetischen verbindungen
|
WO2008086470A1
(en)
|
2007-01-10 |
2008-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
System for optical stimulation of target cells
|
EP2114167B1
(de)
|
2007-01-16 |
2018-07-11 |
University of Rochester |
Nichtmenschliche tiere mit menschlichen gliachimärischen hirnen
|
US8401609B2
(en)
|
2007-02-14 |
2013-03-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
System, method and applications involving identification of biological circuits such as neurological characteristics
|
US20100196328A1
(en)
*
|
2007-04-25 |
2010-08-05 |
Tonya Bliss |
ISCHEMIA-INDUCED NEOVASCULARIZATION IS ENHANCED BY hCNS-SC TRANSPLANTATION
|
US10434327B2
(en)
|
2007-10-31 |
2019-10-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Implantable optical stimulators
|
US10035027B2
(en)
*
|
2007-10-31 |
2018-07-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Device and method for ultrasonic neuromodulation via stereotactic frame based technique
|
WO2009126250A2
(en)
|
2008-04-07 |
2009-10-15 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through rna interference
|
KR20110005280A
(ko)
|
2008-04-23 |
2011-01-17 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
표적 세포의 광학적 자극을 위한 시스템, 방법 및 조성물
|
EP2294208B1
(de)
|
2008-05-29 |
2013-05-08 |
The Board of Trustees of The Leland Stanford Junior University |
Zelllinie, system und verfahren zur optischen steuerung von sekundären botenstoffen
|
MY156389A
(en)
|
2008-06-17 |
2016-02-15 |
Univ Leland Stanford Junior |
Methods, systems and devices for optical stimulation of target cells using an optical transmission element
|
JP5887136B2
(ja)
*
|
2008-06-17 |
2016-03-16 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
細胞発達を制御するための装置および方法
|
WO2010006049A1
(en)
*
|
2008-07-08 |
2010-01-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Materials and approaches for optical stimulation of the peripheral nervous system
|
NZ602416A
(en)
|
2008-11-14 |
2014-08-29 |
Univ Leland Stanford Junior |
Optically-based stimulation of target cells and modifications thereto
|
US20100158878A1
(en)
*
|
2008-12-23 |
2010-06-24 |
Alexandra Capela |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
WO2010111278A1
(en)
|
2009-03-23 |
2010-09-30 |
The Texas A&M University System |
Compositions of mesenchymal stem cells to regenerate bone
|
BRPI0902039B8
(pt)
|
2009-06-09 |
2021-05-25 |
Anhanguera Educacional Ltda |
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
|
US8288158B2
(en)
*
|
2009-06-12 |
2012-10-16 |
Board Of Regents, The University Of Texas System |
Stem cells modified to facilitate threonine catabolism
|
BR112012011183A2
(pt)
|
2009-11-12 |
2015-09-15 |
Vbi Technologies Llc |
sub-população isolada de células similares a esporos e método para isolar uma sub-população de células similares a esporos
|
AU2011227131B2
(en)
|
2010-03-17 |
2014-11-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Light-sensitive ion-passing molecules
|
KR101765980B1
(ko)
|
2010-07-28 |
2017-08-07 |
뉴럴스템, 인크. |
신경퇴행성 질환 및/또는 장애의 치료 및/또는 역전 방법
|
CN103269708A
(zh)
|
2010-10-01 |
2013-08-28 |
Ns基因公司 |
镍纹蛋白用于治疗异常性疼痛、痛觉过敏、自发性疼痛和幻痛的用途
|
EP2635109A4
(de)
|
2010-11-05 |
2014-03-19 |
Univ Leland Stanford Junior |
Optisch gesteuerte zns-funktionsstörungen
|
ES2716819T3
(es)
|
2010-11-05 |
2019-06-17 |
Univ Leland Stanford Junior |
Opsinas quiméricas activadas por luz y métodos de uso de las mismas
|
CN103476456B
(zh)
|
2010-11-05 |
2017-10-03 |
斯坦福大学托管董事会 |
奖赏相关行为的光遗传学控制
|
AU2011323228B2
(en)
|
2010-11-05 |
2016-11-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Control and characterization of memory function
|
WO2012061684A1
(en)
|
2010-11-05 |
2012-05-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Upconversion of light for use in optogenetic methods
|
CA2816990A1
(en)
|
2010-11-05 |
2012-05-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Stabilized step function opsin proteins and methods of using the same
|
US8696722B2
(en)
|
2010-11-22 |
2014-04-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic magnetic resonance imaging
|
US9968376B2
(en)
|
2010-11-29 |
2018-05-15 |
Biomet Manufacturing, Llc |
Patient-specific orthopedic instruments
|
US9241745B2
(en)
|
2011-03-07 |
2016-01-26 |
Biomet Manufacturing, Llc |
Patient-specific femoral version guide
|
US9365628B2
(en)
|
2011-12-16 |
2016-06-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Opsin polypeptides and methods of use thereof
|
WO2013126521A1
(en)
|
2012-02-21 |
2013-08-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for treating neurogenic disorders of the pelvic floor
|
EP2968997B1
(de)
|
2013-03-15 |
2019-06-26 |
The Board of Trustees of the Leland Stanford Junior University |
Optogenetische steuerung des verhaltenszustandes
|
US9636380B2
(en)
|
2013-03-15 |
2017-05-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Optogenetic control of inputs to the ventral tegmental area
|
US9790468B2
(en)
|
2013-03-15 |
2017-10-17 |
Avita Iinternational Ltd. |
Multifunctional immature dental pulp stem cells and therapeutic applications
|
CA2910394A1
(en)
|
2013-04-26 |
2014-10-30 |
Memorial Sloan-Kettering Cancer Center |
Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
|
EP2991491B1
(de)
|
2013-04-29 |
2019-12-25 |
The Board of Trustees of the Leland Stanford Junior University |
Vorrichtungen, systeme und verfahren zur optogenetischen modulation von wirkungspotentialen in zielzellen
|
CA2913993A1
(en)
|
2013-05-31 |
2014-12-04 |
University Of Utah Research Foundation |
Conotoxin peptides, pharmaceutical compositions and uses thereof
|
MX2015017235A
(es)
|
2013-06-13 |
2017-05-04 |
Orgenesis Ltd |
Poblaciones celulares, metodos de transdiferenciacion y metodos de uso de los mismos.
|
CN105829538A
(zh)
|
2013-08-14 |
2016-08-03 |
小利兰·斯坦福大学托管委员会 |
用于控制疼痛的组合物和方法
|
US10779519B2
(en)
|
2014-05-13 |
2020-09-22 |
University Of Rochester |
Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy
|
EP3209306B1
(de)
|
2014-10-20 |
2024-04-24 |
Neuralstem, Inc. |
Stabile neurale stammzellen mit einem exogenen polynukleotid zur codierung eines wachstumsfaktors und verfahren zur verwendung davon
|
MA41296A
(fr)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
WO2016209654A1
(en)
|
2015-06-22 |
2016-12-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and devices for imaging and/or optogenetic control of light-responsive neurons
|
US10722310B2
(en)
|
2017-03-13 |
2020-07-28 |
Zimmer Biomet CMF and Thoracic, LLC |
Virtual surgery planning system and method
|
US11294165B2
(en)
|
2017-03-30 |
2022-04-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
|
EP3635106A4
(de)
|
2017-05-08 |
2021-01-06 |
Orgenesis Ltd. |
Transdifferenzierte zellpopulationen und verfahren zur verwendung davon
|
KR20210054502A
(ko)
|
2018-06-21 |
2021-05-13 |
유니버시티 오브 로체스터 |
헌팅턴병을 치료하거나 이의 발병을 저해하는 방법
|
WO2020167822A2
(en)
|
2019-02-13 |
2020-08-20 |
University Of Rochester |
Gene networks that mediate remyelination of the human brain
|
KR20240006581A
(ko)
|
2021-05-06 |
2024-01-15 |
호바 세라퓨틱스 에이피에스 |
화학요법-유도된 신경병성 통증의 예방 및 치료
|
US20230277600A1
(en)
|
2021-10-20 |
2023-09-07 |
University Of Rochester |
Treatment Of Age-Related White Matter Loss By Competitive Replacement Of Glial Cells
|
WO2023069843A1
(en)
|
2021-10-20 |
2023-04-27 |
University Of Rochester |
Humanized chimeras for the prospective assessment of cell addition and replacement therapies
|
US20230270818A1
(en)
|
2021-11-02 |
2023-08-31 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
WO2023104960A1
(en)
|
2021-12-10 |
2023-06-15 |
Hoba Therapeutics Aps |
Treatment of nociceptive pain
|
WO2023215455A1
(en)
|
2022-05-05 |
2023-11-09 |
University Of Rochester |
Dual macroglial-microglial approach towards therapeutic cell replacement in neurodegenerative and neuropsychiatric disease
|